Thomas J. Herzfeld Advisors, Inc. - KARYOPHARM THERAPEUTICS INC ownership

KARYOPHARM THERAPEUTICS INC's ticker is KPTI and the CUSIP is 48576U106. A total of 160 filers reported holding KARYOPHARM THERAPEUTICS INC in Q3 2020. The put-call ratio across all filers is 0.79 and the average weighting 0.1%.

Quarter-by-quarter ownership
Thomas J. Herzfeld Advisors, Inc. ownership history of KARYOPHARM THERAPEUTICS INC
ValueSharesWeighting
Q2 2021$15,000
-6.2%
1,5000.0%0.01%
-14.3%
Q1 2021$16,000
-30.4%
1,5000.0%0.01%
-36.4%
Q4 2020$23,000
+4.5%
1,5000.0%0.01%
-26.7%
Q3 2020$22,000
-8.3%
1,5000.0%0.02%
+25.0%
Q2 2020$24,000
-17.2%
1,5000.0%0.01%
-20.0%
Q1 2020$29,0000.0%1,5000.0%0.02%
+50.0%
Q4 2019$29,000
+107.1%
1,5000.0%0.01%
+100.0%
Q3 2019$14,000
+55.6%
1,5000.0%0.01%
+66.7%
Q2 2019$9,0000.0%1,5000.0%0.00%0.0%
Q1 2019$9,000
-35.7%
1,5000.0%0.00%
-50.0%
Q4 2018$14,000
-46.2%
1,5000.0%0.01%
-33.3%
Q3 2018$26,000
+4.0%
1,5000.0%0.01%0.0%
Q2 2018$25,000
+25.0%
1,5000.0%0.01%
+12.5%
Q1 2018$20,000
+42.9%
1,5000.0%0.01%
+60.0%
Q4 2017$14,000
-73.6%
1,500
-69.2%
0.01%
-78.3%
Q3 2017$53,000
+20.5%
4,8680.0%0.02%
+21.1%
Q2 2017$44,000
-30.2%
4,8680.0%0.02%
-32.1%
Q1 2017$63,000
+37.0%
4,8680.0%0.03%
+33.3%
Q4 2016$46,000
-2.1%
4,8680.0%0.02%
-16.0%
Q3 2016$47,000
+42.4%
4,8680.0%0.02%
+47.1%
Q2 2016$33,000
-23.3%
4,8680.0%0.02%
-22.7%
Q1 2016$43,000
-33.8%
4,8680.0%0.02%
-15.4%
Q4 2015$65,000
+27.5%
4,8680.0%0.03%
+18.2%
Q3 2015$51,000
-61.4%
4,8680.0%0.02%
-60.0%
Q2 2015$132,000
-11.4%
4,8680.0%0.06%
-20.3%
Q1 2015$149,000
+192.2%
4,868
+255.8%
0.07%
+165.4%
Q4 2014$51,000
+6.2%
1,3680.0%0.03%
-3.7%
Q3 2014$48,0001,3680.03%
Other shareholders
KARYOPHARM THERAPEUTICS INC shareholders Q3 2020
NameSharesValueWeighting ↓
Consonance Capital Management LP 4,767,078$80,993,0005.22%
Palo Alto Investors LP 4,663,324$79,230,0003.17%
DOHENY ASSET MANAGEMENT /CA 282,945$4,807,0002.61%
Private Capital Advisors, Inc. 416,900$7,083,0002.22%
Sandia Holdings, LLC 119,739$2,034,0000.91%
Virtus ETF Advisers LLC 44,986$764,0000.68%
Birchview Capital, LP 50,000$850,0000.58%
Schonfeld Strategic Advisors LLC 415,600$7,061,0000.38%
EMERALD ADVISERS, LLC 561,317$9,537,0000.36%
Kazazian Asset Management, LLC 20,672$351,0000.32%
View complete list of KARYOPHARM THERAPEUTICS INC shareholders